| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/18/2012 | CN102321156A Novel thymopentin compound and composition powder injection thereof |
| 01/18/2012 | CN102321155A Tumor necrosis factor (TNF) binding peptide and TNFR1 blocking peptide, and application thereof in treatment of ulcerative colitis |
| 01/18/2012 | CN102321154A Radiolabelled peptide based compounds and uses thereof |
| 01/17/2012 | US8097590 Melanocyte Stimulating Hormone; new peptides and peptidic conjugates containing at least 6 amino acids and including the sequence DPhe-Arg have a substantial activating effect on melanogenesis in the melanocytes of the hair bulb |
| 01/17/2012 | US8097589 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting mucous release into airways of patients; immunotherapy |
| 01/17/2012 | US8097582 Peptide derivatives useful as antimicrobial agents and for treating wounds |
| 01/12/2012 | WO2012006497A2 Mu opioid receptor agonist analogs of the endomorphins |
| 01/12/2012 | WO2012005313A1 Cyclic peptide compound or pharmacologically acceptable salt thereof and method for producing same |
| 01/12/2012 | WO2011145077A3 Branched polypeptides and their use in promoting adhesion of cells to solid surfaces |
| 01/12/2012 | WO2003085121A9 Nucleic acid and corresponding protein entitled 213p1f11 useful in treatment and detection of cancer |
| 01/12/2012 | US20120010266 Tbc1d7 as tumor marker and therapeutic target for cancer |
| 01/12/2012 | US20120010153 Novel tumor-targeting compounds |
| 01/12/2012 | US20120010151 Use of wnt5-a peptide derivates for the treatment of melanoma and gastric cancer |
| 01/12/2012 | US20120010147 Nmdar biomarkers for diagnosis and treatment of traumatic brain injury and other disorders |
| 01/12/2012 | US20120010136 Use of cd31 peptides in the treatment of thrombotic and autoimmune disorders |
| 01/12/2012 | US20120010131 Novel cyclosporin analogues |
| 01/12/2012 | US20120009605 New assays for preimplantation factor and preimplantation factor peptides |
| 01/12/2012 | US20120009124 Use of buffers for radionuclide complexation |
| 01/12/2012 | CA2810170A1 Mu opioid receptor agonist analogs of the endomorphins |
| 01/11/2012 | EP2404932A1 Polypeptides and antibacterial or antiseptic use of same |
| 01/11/2012 | EP2403964A2 Methods and products for in vivo enzyme profiling |
| 01/11/2012 | EP2403943A1 Vangl1 peptides and vaccines including the same |
| 01/11/2012 | EP2403871A1 Antibodies and epitopes specific to misfolded prion protein |
| 01/11/2012 | EP2403539A2 Methods and systems for treatment and/or diagnosis |
| 01/11/2012 | EP1853620B1 Antimicrobial hexapeptides |
| 01/11/2012 | EP1572121B1 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 01/11/2012 | EP1448593B1 Alpha-fetoprotein peptides and uses thereof |
| 01/11/2012 | EP1438586B1 Fret protease assays for clostridial toxins |
| 01/11/2012 | CN102317307A Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions |
| 01/11/2012 | CN102317257A Process for the preparation of asymmetrical bis(thiosemicarbazones) |
| 01/11/2012 | CN102316886A Skin aging-inhibiting peptide |
| 01/11/2012 | CN102311486A Method for separating and extracting enramycin by using macroporous weakly-acidic cationic resin |
| 01/11/2012 | CN102311485A Polypeptide with neovascularization suppression effect and application thereof |
| 01/11/2012 | CN102311484A Hexapeptide for inhabiting angiotensin transferase and preparation method thereof |
| 01/11/2012 | CN102311483A Lowly hemolytic antimicrobial lipopeptide and preparation method thereof |
| 01/11/2012 | CN102020701B Hemagglutinin protein affinity peptide of influenza A H1N1 virus |
| 01/11/2012 | CN101914140B Scorpion source antivirus active polypeptide and application thereof |
| 01/11/2012 | CN101781357B Polypeptide for detecting human cancer cells, and application thereof |
| 01/11/2012 | CN101570569B Synthetic antibacterial peptide and preparation method and application thereof |
| 01/10/2012 | US8093218 Peptide derived from vascular endothelial growth factor receptor-1 binding integrin α5β1 having proangiogenic activity |
| 01/10/2012 | US8093046 CVN-12p1: a recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions |
| 01/10/2012 | US8092788 Compositions and methods for topical diagnostic and therapeutic transport |
| 01/10/2012 | CA2490172C Diagnosis of recent tuberculosis infection by comparing t-cell antigenicity of esat-6 with epitopes thereof |
| 01/10/2012 | CA2484467C Fluorescence-based methods for measuring enzyme activity |
| 01/10/2012 | CA2398726C High purity lipopeptides, lipopeptide micelles and processes for preparing same |
| 01/05/2012 | WO2012002762A2 Peptide for the treatment or prevention of allergic diseases |
| 01/05/2012 | WO2012002668A2 Novel peptide and use thereof |
| 01/05/2012 | WO2012001245A1 Sirtuin-6-activating peptides, and cosmetic or pharmaceutical compositions including same |
| 01/05/2012 | WO2012000409A1 Peptides with activity of inhibiting angiogenesis and uses thereof |
| 01/05/2012 | WO2012000118A1 Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof |
| 01/05/2012 | WO2011115819A3 Small molecule inhibitors of muc1 and methods of identifying the same |
| 01/05/2012 | WO2010146420A8 Synthetic oligopeptides designed from mite cysteine proteases and methods for the production of igy polyclonal antibodies for the detection of intradomiciliary mites |
| 01/05/2012 | US20120005790 Analogs of temporin-sha and uses thereof |
| 01/05/2012 | US20120004720 G-type peptides and other agents to ameliorate atherosclerosis and other pathologies |
| 01/05/2012 | US20120004393 Potent Compstatin Analogs |
| 01/05/2012 | US20120004168 Exendins and exendin agonist analogs to regulate gastrointestinal motility |
| 01/05/2012 | US20120003712 Method for preparing a site-specific physiologically active polypeptide conjugate |
| 01/05/2012 | US20120003629 Biological control of nanoparticle nucleation, shape and crystal phase |
| 01/05/2012 | US20120003269 Compositions Produced Using Enteric Pathogens and Methods of Use |
| 01/05/2012 | US20120003253 C1orf59 peptides and vaccines including the same |
| 01/05/2012 | US20120003247 Monomethylvaline compounds capable of conjugation to ligands |
| 01/05/2012 | US20120003203 Compositions and Methods for Treating S. Pneumoniae Infection |
| 01/05/2012 | US20120003201 Vault agents for chronic kidney disease |
| 01/05/2012 | US20120003119 Antimicrobial peptides |
| 01/05/2012 | CA2803646A1 Short and d-amino acid-containing polypeptides for therapeutic conjugates and uses thereof |
| 01/05/2012 | CA2801010A1 Novel peptide and use thereof |
| 01/04/2012 | EP2402366A1 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, und use thereof |
| 01/04/2012 | EP2402364A2 A nonapeptide with anti-tumour activity |
| 01/04/2012 | EP2402030A1 Linear IgE peptide epitopes of celery allergen api 1 |
| 01/04/2012 | EP2402026A2 Method for isolating hepatitis C virus peptides |
| 01/04/2012 | EP2402009A1 Inhibitors of serine protease, particularly hepatitis c virus NS3-NS4A protease, incorporating a fused ring system |
| 01/04/2012 | EP1441720B1 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4a protease, incorporating a fused ring system |
| 01/04/2012 | EP1187850B1 Antimicrobial theta defensins and methods of using same |
| 01/04/2012 | CN102307904A Conjugates of neurotensin or neurotensin analogs and uses thereof |
| 01/04/2012 | CN102307893A Peptides for vaccine |
| 01/04/2012 | CN102307892A Derivatives of cyclosporin A |
| 01/04/2012 | CN102307891A WDRPUH epitope peptides and vaccines containing the same |
| 01/04/2012 | CN102305855A Reagent and method for detecting Mycobacterium tuberculosis infection in vitro |
| 01/04/2012 | CN102304171A Three alpha-conus polypeptides and use thereof |
| 01/04/2012 | CN102304170A Horn polypeptide, and separation method and antioxidation application thereof |
| 01/04/2012 | CN101665530B Antiphytoviral black pleurotus ostreatus protein as well as preparation method and application thereof |
| 01/04/2012 | CN101607982B Fish skin collagen peptide with whitening effect and preparation process and application thereof |
| 01/03/2012 | US8088890 Peptides and peptidomimetic compounds, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| 01/03/2012 | US8088887 Nucleic acids, peptides, and antibodies for use in diagnosis and therapy; macular degeneration; cancers of the colon, breasts, prostate, liver, pancreas, and mouth; receptor binding assays of the peptide to neovasulatures |
| 01/03/2012 | US8088886 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 01/03/2012 | CA2636432C Peptides and compounds that bind to a thrombopoietin receptor |
| 01/03/2012 | CA2347025C Zinc finger binding domains for gnn |
| 01/03/2012 | CA2215483C Non-toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same |
| 12/29/2011 | WO2011163398A2 Biomimetic peptides for bone augmentation |
| 12/29/2011 | WO2011161191A1 Peptides incorporating 3-aminoadamantane carboxylic acids enhance synaptic plasticity and act as neurogenic agents |
| 12/29/2011 | WO2011160827A2 Novel jnk inhibitor molecules |
| 12/29/2011 | WO2011160664A1 Treatment of vascular complications of diabetes |
| 12/29/2011 | WO2011160653A1 Novel jnk inhibitor molecules |
| 12/29/2011 | WO2011114071A3 Synthetic cyclopeptide, preparation process and uses |
| 12/29/2011 | WO2011103311A3 Treatments for gastrointestinal disorders |
| 12/29/2011 | WO2011097633A3 Egf receptor mimicking peptides |
| 12/29/2011 | US20110319599 MN Gene and Protein |
| 12/29/2011 | US20110319594 Method for producing bivalirudin |
| 12/29/2011 | US20110319343 Agonists Of Guanylate Cyclase Useful For The Treatment Of Gastrointestinal Disorders, Inflammation, Cancer And Other Disorders |
| 12/29/2011 | US20110319339 Neurotensin-derived branched peptides and uses thereof |